Abstract:PurposeG Protein-Coupled Receptors (GPCRs) are a large family of therapeutically important proteins and as diverse X-ray structures become available it is increasingly possible to leverage structural information for rational drug design.We present herein approaches that use explicit water networks combined with energetic surveys of the binding site (GRID), providing an enhanced druggability and ligand design approach, with structural understanding of ligand binding, including a ‘magic’ methyl and binding site mutations, and a fast new approach to generate and score waters.MethodsThe GRID program was used to identify lipophilic and hydrogen bonding hotspots. Explicit full water networks were generated and scored for (pseudo)apo structures and ligand-protein complexes using a new approach, WaterFLAP (Molecular Discovery), together with WaterMap (Schrödinger) for (pseudo)apo structures. A scoring function (MetaScore) was developed using a fast computational protocol based on several short adiabatic biased MD simulations followed by multiple short well-tempered metadynamics runs.ResultsAnalysis of diverse ligands binding to the adenosine A2A receptor together with new structures for the δ/κ/μ opioid and CCR5 receptors confirmed the key role of lipophilic hotspots in driving ligand binding and thus design; the displacement of ‘unhappy’ waters generally found in these regions provides a key binding energy component. Complete explicit water networks could be robustly generated for protein-ligand complexes using a WaterFLAP based approach. They provide a structural understanding of structure-activity relationships such as a ‘magic methyl’ effect and with the metadynamics approach a useful estimation of the binding energy changes resulting from active site mutations.ConclusionsThe promise of full structure-based drug design (SBDD) for GPCRs is now possible using a combination of advanced experimental and computational data. The conformational thermostabilisation of StaR® proteins provide the ability to easily generate biophysical screening data (binding including fragments, kinetics) and to get crystal structures with both potent and weak ligands. Explicit water networks for apo and ligand-complex structures are a critical ‘third dimension’ for SBDD and are key for understanding ligand binding energies and kinetics. GRID lipophilic hotspots are found to be key drivers for binding. In this context ‘high end’ GPCR ligand design is now enabled.

A resource to enable chemical biology and drug discovery of WDR Proteins

A Target Class Ligandability Evaluation of WD40 Repeat-Containing Proteins

Identification and Validation of WDR5 WIN-site Ligands Via DNA-encoded Chemical Library Screening

WDSPdb: an Updated Resource for WD40 Proteins

Phage-Display Based Discovery and Characterization of Peptide Ligands against WDR5

A ligand discovery toolbox for the WWE domain family of human E3 ligases

Wdspdb: A Database for Wd40-Repeat Proteins

Discovery and Optimization of WDR5 Inhibitors via Cascade Deoxyribonucleic Acid-Encoded Library Selection Approach

Targeting WD Repeat-Containing Protein 5 (WDR5): A Medicinal Chemistry Perspective

Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models

CACHE Challenge #1: targeting the WDR domain of LRRK2, a Parkinson's Disease associated protein.

DrugBank: a comprehensive resource for in silico drug discovery and exploration

Screening and Optimization of Phage Display Cyclic Peptides Against the WDR5 WBM Site

High end GPCR design: crafted ligand design and druggability analysis using protein structure, lipophilic hotspots and explicit water networks

Discovery of a Novel DCAF1 Ligand Using a Drug–Target Interaction Prediction Model: Generalizing Machine Learning to New Drug Targets

The Future of Medicinal Chemistry, PROTAC, and Undruggable Drug Targets

A Method for WD40 Repeat Detection and Secondary Structure Prediction.

Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cells

Large-scale Direct Targeting for Drug Repositioning and Discovery

Identification of WD40 Repeats by Secondary Structure-Aided Profile-Profile Alignment.

Chemical Proteomics-based Target Prioritization through a Residue Agnostic Ligandability Assessment Platform